JNJ
NYSE
$248.94
Johnson & Johnson (JNJ)
Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies, and is one of only two U.S.-based companies that has a prime credit rating of AAA, higher than that of the United States government.
Sector:
Healthcare
Industry:
Drug Manufacturers - General
Buy
Target: $269.95 (+8.44%)
Market Cap
$595B
Profit Margin
21.8%
Forward P/E
21.74
P/E Ratio
22.09
Price Chart
Valuation
Market Cap$595B
P/E22.09
Forward P/E21.74
PEG4.95
P/S6.34
P/B7.64
Profitability
Total Revenue (TTM)$96B
Gross Profit (TTM)$67B
EBITDA$34B
Profit Margin21.8%
Operating Margin26.6%
EPS$11.18
Financial Health
Debt-to-Equity67.7%
Free Cash Flow Yield2.99%
Dividend Yield2.10%
Growth & Risk
EPS 5Y CAGR+11.59%
Revenue 5Y CAGR+2.73%
FCF 5Y CAGR-3.13%
Dividends 5Y CAGR+9.84%
Beta (5Y)-0.02
Sharpe Ratio2.37